There is too much guesswork in the treatment of Major Depressive Disorder.

1 in 3 people treated for MDD won’t experience a meaningful improvement of their symptoms. We believe data and machine learning can be used to match people to effective treatments faster. Fewer people will suffer. Fewer people will die from depression.

This is why we started Eiro.

Our platform enables shared, data-informed decision-making in real-world depression care.

Reliable stats about treatment efficacy, tailored to you.

Recommendations about treatment selection and data collection.

Updated to reflect your care journey in real-time.

Delivered to clinicians and patients alike.

Learn more about what we’re building

There is too much guesswork in the treatment of Major Depressive Disorder.

1 in 3 people treated for MDD won’t experience a meaningful improvement of their symptoms. We believe data and machine learning can be used to match people to effective treatments faster. Fewer people will suffer. Fewer people will die from depression.

This is why we started Eiro.

Our platform enables shared, data-informed decision-making in real-world depression care.

Reliable stats about treatment efficacy, tailored to you.

Recommendations about treatment selection and data collection.

Updated to reflect your care journey in real-time.

Delivered to clinicians and patients alike.

Learn more about what we’re building

There is too much guesswork in the treatment of Major Depressive Disorder.

1 in 3 people treated for MDD won’t experience a meaningful improvement of their symptoms. We believe data and machine learning can be used to match people to effective treatments faster. Fewer people will suffer. Fewer people will die from depression.

This is why we started Eiro.

Our platform enables shared, data-informed decision-making in real-world depression care.

Reliable stats about treatment efficacy, tailored to you.

Recommendations about treatment selection and data collection.

Updated to reflect your care journey in real-time.

Delivered to clinicians and patients alike.

Learn more about what we’re building